Christian Jackisch Selected Research

Taxoids (Taxanes)

4/2012	Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion.
10/2004	Future options with trastuzumab for primary systemic and adjuvant therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Jackisch Research Topics

Disease

150	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2002
52	Neoplasms (Cancer) 05/2024 - 10/2002
18	Pathologic Complete Response 11/2023 - 04/2010
13	Triple Negative Breast Neoplasms 04/2024 - 09/2013
10	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 09/2003
7	Carcinoma (Carcinomatosis) 12/2023 - 12/2003
7	Neutropenia 01/2021 - 09/2006
6	Diarrhea 02/2024 - 04/2007
5	Cardiotoxicity 06/2021 - 10/2005
5	Febrile Neutropenia 01/2021 - 11/2008
5	Exanthema (Rash) 01/2016 - 02/2012
5	Infections 07/2015 - 03/2009
4	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2006
4	Ovarian Epithelial Carcinoma 01/2017 - 08/2006
3	Disease Progression 12/2023 - 10/2004
3	Inflammatory Breast Neoplasms 11/2019 - 01/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 09/2013
3	Hand-Foot Syndrome 01/2012 - 04/2010
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2006 - 10/2004
2	Residual Neoplasm 01/2023 - 01/2019
2	Brain Neoplasms (Brain Tumor) 02/2022 - 01/2010
2	Heart Failure 03/2016 - 03/2010
2	Thrombocytopenia (Thrombopenia) 06/2014 - 07/2013
2	Lobular Carcinoma 02/2014 - 06/2013
2	Hypertension (High Blood Pressure) 09/2013 - 01/2012
1	Lymphatic Metastasis 02/2024

Drug/Important Bio-Agent (IBA)

41	Trastuzumab (Herceptin)FDA Link 12/2022 - 10/2004
30	Hormones (Hormone)IBA 03/2024 - 04/2005
25	human ERBB2 proteinIBA 05/2023 - 01/2006
25	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2003
23	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2002
22	taxaneIBA 12/2023 - 01/2006
18	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 03/2010
16	AnthracyclinesIBA 12/2023 - 01/2009
13	Lapatinib (GW572016)FDA Link 01/2021 - 01/2010
12	Docetaxel (Taxotere)FDA Link 01/2018 - 10/2002
11	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 09/2003
10	130-nm albumin-bound paclitaxelIBA 11/2023 - 04/2012
10	ErbB Receptors (EGF Receptor)IBA 01/2023 - 03/2010
9	Capecitabine (Xeloda)FDA Link 11/2023 - 04/2008
8	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2012
8	Phenobarbital (Luminal)FDA Link 12/2023 - 05/2012
8	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013 - 10/2002
7	pertuzumabIBA 10/2022 - 03/2013
7	PlatinumIBA 01/2020 - 10/2006
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2008
6	Estrogen ReceptorsIBA 01/2018 - 10/2004
5	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 01/2019
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 10/2004
5	Tamoxifen FDA LinkGeneric 12/2008 - 10/2002
4	Aromatase InhibitorsIBA 02/2024 - 02/2007
4	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 07/2010
3	Ibandronic Acid (Boniva)FDA Link 11/2023 - 10/2011
3	Epidermal Growth Factor (EGF)IBA 10/2021 - 02/2014
3	AlbuminsIBA 01/2019 - 03/2009
3	Cytotoxins (Cytolysins)IBA 01/2019 - 10/2004
3	Monoclonal AntibodiesIBA 01/2017 - 10/2005
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2006
3	Vinorelbine (Navelbine)FDA LinkGeneric 08/2013 - 04/2008
2	exemestane (Aromasin)FDA Link 03/2024 - 12/2008
2	Everolimus FDA Link 03/2024 - 07/2013
2	Letrozole (Femara)FDA LinkGeneric 02/2024 - 02/2024
2	neratinibIBA 02/2024 - 10/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2021
2	Denosumab FDA Link 11/2023 - 01/2022
2	IceIBA 11/2023 - 10/2015
2	trastuzumab deruxtecanIBA 11/2023 - 11/2022
2	Estrogens (Estrogen)FDA Link 05/2023 - 04/2002
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 05/2021 - 05/2021
2	Anastrozole (Arimidex)FDA LinkGeneric 06/2020 - 05/2013
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 04/2017
2	SolventsIBA 01/2019 - 03/2016
2	Biosimilar PharmaceuticalsIBA 04/2017 - 01/2015
2	Indicators and Reagents (Reagents)IBA 04/2017 - 12/2010
2	ParaffinIBA 10/2016 - 02/2006
2	AntibodiesIBA 03/2013 - 01/2009
2	Taxoids (Taxanes)IBA 04/2012 - 10/2004
2	Gemcitabine FDA Link 09/2010 - 10/2006
2	Tyrosine Kinase InhibitorsIBA 01/2010 - 01/2009
2	SteroidsIBA 01/2009 - 02/2006
2	Estrogen Receptor alphaIBA 03/2005 - 10/2004
1	durvalumabIBA 04/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2023
1	Fibroblast Growth Factor 1 (FGF-1)IBA 12/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	LigandsIBA 12/2023

Therapy/Procedure

74	Therapeutics 05/2024 - 10/2004
54	Neoadjuvant Therapy 11/2023 - 10/2002
48	Drug Therapy (Chemotherapy) 05/2024 - 09/2003
9	Adjuvant Chemotherapy 01/2017 - 10/2005
5	Radiotherapy 02/2024 - 02/2011
3	Subcutaneous Injections 12/2022 - 01/2021
3	Drug Tapering 04/2014 - 09/2006
2	Molecular Targeted Therapy 11/2023 - 11/2022
2	Operative Surgical Procedures 10/2021 - 11/2006
2	Intravenous Infusions 01/2021 - 01/2016
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2018
2	Mastectomy (Mammectomy) 11/2019 - 01/2010
2	Aftercare (After-Treatment) 11/2018 - 10/2018